Delivery Order SPE2DB22D3501-SPE2DB24FVG50
Award Date 4/12/24
Potential Completion Date 4/15/24
Potential Value $4.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 500 mg/50 ml vials of the pharmaceutical RUXIENCE. The $2,837.28 contract has a performance period through January 31, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a $19,118.40 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide RUXIENCE 500 MG/50 ML VIAL 50ML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $9,457.40 contract is for the delivery of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order falls under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that was awarded solely to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of RUXIENCE 100 MG/10 ML VIAL 10ML medical supplies. The contract, valued at $1,218.60, was awarded on June 25, 2024, with a completion date of June 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA), a defense agency. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,728.70 firm fixed price delivery order is for the supply of RUXIENCE 500 MG/50 ML VIAL 50ML, a pharmaceutical product. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.51 to AmerisourceBergen Drug Corp for Ruxience 500 mg/50 ml vials on December 15, 2025, with completion scheduled for December 16, 2025. This competitively awarded, firm fixed-price order represents a continuation of the company's substantial pharmaceutical supply relationship with DLA. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $49,853.74 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has an ultimate completion date of April 18, 2024 and is not set aside. Amerisourcebergen, a major pharmaceutical distributor, will provide a range of prescription medications, over-the-counter drugs, and medical supplies to support the DLA's medical supply chain operations. This delivery order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of pharmaceuticals and medical supplies. The contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) with DLA, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $8,668.40 to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a wide range of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a $396,555.98 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, which is a subsidiary of Amerisourcebergen Corporation. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, allowing the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities...